Literature DB >> 28866845

CORR Insights®: What Should Define Preoperative Anemia in Primary THA?

Matthew P Abdel1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28866845      PMCID： PMC5638755          DOI： 10.1007/s11999-017-5485-4

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  9 in total

1.  Tranexamic Acid Was Safe in Arthroplasty Patients With a History of Venous Thromboembolism: A Matched Outcome Study.

Authors:  Orlando D Sabbag; Matthew P Abdel; Adam W Amundson; Dirk R Larson; Mark W Pagnano
Journal:  J Arthroplasty       Date:  2017-02-14       Impact factor: 4.757

2.  Implications of revision total elbow arthroplasty on blood transfusion.

Authors:  Matthew P Abdel; Bernard F Morrey
Journal:  J Shoulder Elbow Surg       Date:  2009-11-02       Impact factor: 3.019

3.  Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty.

Authors:  Christopher M Duncan; Blake P Gillette; Adam K Jacob; Rafael J Sierra; Joaquin Sanchez-Sotelo; Hugh M Smith
Journal:  J Arthroplasty       Date:  2014-09-06       Impact factor: 4.757

4.  Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty.

Authors:  Blake P Gillette; Lori J DeSimone; Robert T Trousdale; Mark W Pagnano; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

5.  Perioperative solutions for rapid recovery joint arthroplasty: get ahead and stay ahead.

Authors:  Peter K Sculco; Mark W Pagnano
Journal:  J Arthroplasty       Date:  2015-01-30       Impact factor: 4.757

6.  Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty.

Authors:  Blake P Gillette; Hilal Maradit Kremers; Christopher M Duncan; Hugh M Smith; Robert T Trousdale; Mark W Pagnano; Rafael J Sierra
Journal:  J Arthroplasty       Date:  2013-07-23       Impact factor: 4.757

7.  Tranexamic Acid Benefits Total Joint Arthroplasty Patients Regardless of Preoperative Hemoglobin Value.

Authors:  Daniel R Whiting; Christopher M Duncan; Rafael J Sierra; Hugh M Smith
Journal:  J Arthroplasty       Date:  2015-06-03       Impact factor: 4.757

8.  A Three-arm Randomized Clinical Trial Comparing Continuous Femoral Plus Single-injection Sciatic Peripheral Nerve Blocks versus Periarticular Injection with Ropivacaine or Liposomal Bupivacaine for Patients Undergoing Total Knee Arthroplasty.

Authors:  Adam W Amundson; Rebecca L Johnson; Matthew P Abdel; Carlos B Mantilla; Jason K Panchamia; Michael J Taunton; Michael E Kralovec; James R Hebl; Darrell R Schroeder; Mark W Pagnano; Sandra L Kopp
Journal:  Anesthesiology       Date:  2017-06       Impact factor: 7.892

9.  Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities.

Authors:  Daniel R Whiting; Blake P Gillette; Christopher Duncan; Hugh Smith; Mark W Pagnano; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2014-01       Impact factor: 4.176
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.